Electrophysiologic effects of nibentan (HE-11) on canine cardiac tissue. 1997

E P Anyukhovsky, and E A Sosunov, and M R Rosen
Department of Pharmacology and Pediatrics, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.

We studied the effects of nibentan on transmembrane action potentials of canine Purkinje fibers (PF), ventricular epicardial and endocardial tissues and atrial tissue. Nibentan (1 x 10(-8) to 5 x 10(-6) M) had no effects on maximum diastolic potential of all tissues and produced a modest concentration- and use-dependent decrease in V(max). However, a remarkable tissue specificity was observed in its effects on action potential duration (APD). In PF, the concentration-dependent effect was biphasic: maximum APD prolongation was attained at 10(-7) M, and a decrease in APD was seen at higher concentrations. In contrast, in ventricular tissue, nibentan prolonged APD monotonically to a steady state at 10(-6) M. In atrial tissue, a monotonic, concentration-dependent increase in APD was observed through the highest concentration. The ability of nibentan to prolong PF APD significantly diminished as the cycle length shortened (from 2000 to 300 ms), whereas in ventricular and atrial tissues, it showed no reverse use-dependence. In the physiological range of cycle length, nibentan did not enhance the spatial inhomogeneity of repolarization. In PF, it prolonged APD, slightly inhibited V(max) of Ca++-induced action potentials and completely eliminated the effects of isoproterenol on normal automaticity. We conclude that 1) nibentan is an antiarrhythmic with a profound ability to prolong repolarization while decreasing heterogeneity of repolarization and 2) the extent of nibentan's APD prolongation effect is significantly different in different cardiac tissues.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001549 Benzamides BENZOIC ACID amides.

Related Publications

E P Anyukhovsky, and E A Sosunov, and M R Rosen
September 1994, Journal of cardiovascular pharmacology,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
March 1973, The Journal of pharmacology and experimental therapeutics,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
August 1984, The American journal of cardiology,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
December 1998, Journal of cardiovascular pharmacology,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
May 1974, The Journal of pharmacology and experimental therapeutics,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
June 1977, The Journal of pharmacology and experimental therapeutics,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
December 1983, Journal of the American College of Cardiology,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
July 1971, The Journal of pharmacology and experimental therapeutics,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
January 1991, Pediatric research,
E P Anyukhovsky, and E A Sosunov, and M R Rosen
October 1989, Anesthesiology,
Copied contents to your clipboard!